Update on the role of Rifaximin in digestive diseases

A Gasbarrini, FR Ponziani, G Ianiro, J Trna… - … and Liver Diseases, 2023 - repositorio.ul.pt
Various environmental factors affecting the human microbiota may lead to gut microbial
imbalance and to the development of pathologies. Alterations of gut microbiota have been …

Prophylaxis of hepatic encephalopathy: current and future drug targets

S Maharshi, BC Sharma - Hepatology International, 2024 - Springer
Hepatic encephalopathy is described by a broad spectrum of neurological and psychiatric
aberrations resulting due to advanced liver dysfunction. It is a neurological disorder due to …

[HTML][HTML] Is rifaximin better than nonabsorbable disaccharides in hepatic encephalopathy?: A meta-analysis

J Cheng, Y Chen, W Cao, G Zuo - Medicine, 2021 - journals.lww.com
Background: The purpose of the present meta-analysis was to compare the efficacy of
rifaximin and nonabsorbable disaccharides (NADs) in hepatic encephalopathy (HE) …

Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review

A Deljavan Ghodrati, T Comoglu - Archiv der Pharmazie, 2024 - Wiley Online Library
Rifaximin, a broad‐spectrum antibiotic, boasts a unique chemical composition and
pharmacokinetic profile, rendering it highly effective in treating irritable bowel syndrome …

Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis

G Fang, S Liu, B Liu - BMC gastroenterology, 2024 - Springer
Background Hepatic encephalopathy (HE) is a neuropsychiatric syndrome that affects the
prognosis of patients with liver disease and is considered an independent risk factor for …

Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis

HD Zacharias, F Kamel, J Tan, N Kimer… - Cochrane Database …, 2023 - cochranelibrary.com
Background Hepatic encephalopathy describes the spectrum of neuropsychiatric changes
that may complicate the course of cirrhosis and detrimentally affect outcomes. Ammonia …

[HTML][HTML] Efficacy and Safety of Variable Treatment Options in the Prevention of Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis

M Hammd, A Elghezewi, A Abdulhadi, A Alabid… - Cureus, 2024 - ncbi.nlm.nih.gov
There are no guidelines for the most effective medication to reduce hepatic encephalopathy
(HE) or the associated mortality. The purpose of this study is to determine the most effective …

Современные возможности применения лактулозы в клинической практике

АА Шептулин - Российский журнал гастроэнтерологии, гепатологии …, 2023 - gastro-j.ru
Основные положения. Лактулоза является синтетическим дисахаридом, относящимся к
классу осмотических слабительных. Официально разрешенными показаниями к её …

[HTML][HTML] Efficacy and Safety of Rifaximin in the Prevention of Recurrent Episodes of Hepatic Encephalopathy: A Systematic Review and Meta-analysis

A Elmoursi, AT Abdelsattar, F Khalil… - The Turkish Journal …, 2023 - ncbi.nlm.nih.gov
Background: Rifaximin is an oral antimicrobial drug with a broad-spectrum effect. It locally
regulates the function and structure of intestinal bacteria and decreases intestinal …

[PDF][PDF] Modern Possibilities of Using Lactulose in Clinical Practice

AA Sheptulin - Главный редактор, 1994 - gastro-j.ru
Аim: to present an overview of current literature data on the possibilities of application of
lactulose in clinical practice. Key points. Lactulose is a synthetic disaccharide belonging to …